| Literature DB >> 31428437 |
Hassan Dastsooz1, Mohsen Alipour1, Sanaz Mohammadi1, Fatemeh Kamgarpour1, Fatemeh Dehghanian1, Majid Fardaei1,2.
Abstract
GM2 gangliosides are a group of lysosomal lipid storage disorders that are due to mutations in HEXA, HEXB and GM2A. In our study, 10 patients with these diseases were enrolled, and Sanger sequencing was performed for the HEXA and HEXB genes. The results revealed one known splice site mutation (c.346+1G>A, IVS2+1G>A) and three novel mutations (a large deletion involving exons 6-10; one nucleotide deletion, c.622delG [p.D208Ifsx15]; and a missense mutation, c.919G>A [p.E307K]) in HEXA. In HEXB, one known mutation (c.1597C>T [p.R533C]) and one variant of uncertain significance (c.619A>G [p.I207V]) were identified. Five patients had c.1597C>T in HEXB, indicating a common mutation in south Iran. In this study, a unique large deletion in HEXA was identified as a homozygous state. To predict the cause of the large deletion in HEXA, RepeatMasker was used to investigate the Alu elements. In addition, to identify the breakpoint of this deletion, PCR was performed around these elements. Using Repeat masker, different Alu elements were identified across HEXA, mainly in intron 5 and intron 10 adjacent to the deleted exons. PCR around the Alu elements and Sanger sequencing revealed the start point of a large deletion in AluSz6 in the intron 6 and the end of its breakpoint 73 nucleotides downstream of AluJo in intron 10. Our study showed that HEXA is an Alu-rich gene that predisposes individuals to disease-associated large deletions due to these elements.Entities:
Year: 2018 PMID: 31428437 PMCID: PMC6694291 DOI: 10.1038/hgv.2018.3
Source DB: PubMed Journal: Hum Genome Var ISSN: 2054-345X
All of the primer pairs used in the current study
| FE1 | 5ʹ- CGGTTATTTACTGCTCTACTGG-3ʹ | FE1 | 5ʹ- TGTTTGAGGTTGCTGTCTGG-3ʹ |
| RE1 | 5ʹ- GAAGTGGAGTGCCTGTGA-3ʹ | RE1 | 5ʹ- TCGAAACTGAGGACTTCTGC-3ʹ |
| FE2 | 5ʹ- TCCTCCCTTTCCTTTACC-3ʹ | FE2 | 5ʹ- ATCTCTAGTTGGACTTACAATG-3ʹ |
| RE2 | 5ʹ- CGAGCATCAGCAGTTTAG-3ʹ | RE2 | 5ʹ- CTCATCCATATAGTGACAGAAC-3ʹ |
| FE3 | 5ʹ- GACATCTCCTCATTGAAAGA-3ʹ | FE3 | 5ʹ- TGAAATGAGGAACACAGAAGAC-3ʹ |
| RE3 | 5ʹ- ACACCTGTAATCCCAGAAC-3ʹ | RE3 | 5ʹ- TCACAAAGCACCAACTGAA-3ʹ |
| FE4 | 5ʹ- AACCCTTACTCTGACATCTC-3ʹ | FE4-5 | 5ʹ- TTAGAGGATAGAGGTATAACACTA-3ʹ |
| RE4 | 5ʹ- CACTCACATCTCCTCTTCCA-3ʹ | RE4-5 | 5ʹ- AAACAGGAGGGTGATTCTC-3ʹ |
| FE5 | 5ʹ- TGAGAACAGTCACAGATTG-3ʹ | FE6 | 5ʹ- AAGCAGACATATTGGAAGCA-3ʹ |
| RE5 | 5ʹ- ACACCCAGTCCATACATTC-3ʹ | RE6 | 5ʹ- AGCCTACATACCTAACATTGG-3ʹ |
| FE6-7 | 5ʹ- ATGGGAAGGTTTGATAGAC-3ʹ | FE7 | 5ʹ- TCCTTTGAGTATGTACGACTTAG-3ʹ |
| RE6-7 | 5ʹ- TCACTCTGAGCATAACAAG-3ʹ | RE7 | 5ʹ- CAGTGAGCCGAGATTGTAC-3ʹ |
| FE8 | 5ʹ- GTGTGACTCGTGTCCTTAC-3ʹ | FE8 | 5ʹ- AAGAGACAGGATTCAGGA-3ʹ |
| RE8 | 5ʹ- AAGACCTGAGCAATGTGAG-3ʹ | RE8 | 5ʹ- AGTACAGTGGCATGATCTCAG-3ʹ |
| FE9-10 | 5ʹ- CCACCTGCTTCACATAACT-3ʹ | FE9 | 5ʹ- AGGTGGTAAGGTAAAGAAAGC-3ʹ |
| R9-10 | 5ʹ- GAGAGTGCTCCGACCATTA-3ʹ | RE9 | 5ʹ- AAGCAAGCAGTGGGTATTG-3ʹ |
| FE11-12-13 | 5ʹ- CATGTTGCCTGTGTATGAAT-3ʹ | FE10-11 | 5ʹ- CTATGTTAGGTTCTGTATCAAG-3ʹ |
| RE11-12-13 | 5ʹ- AAGCCTCTGTAAGTGTTAGC-3ʹ | RE10-11 | 5ʹ- ACAATGGTTGCTTCACTTAC-3ʹ |
| FE14New | 5ʹ- ACAGTGACAGTTTGAGAGTC-3ʹ | FE12-14 | 5ʹ- ATTGCCTCTGTGTATAAG-3ʹ |
| RE14New | 5ʹ- TGCCTATTAATTCCAGTTACT-3ʹ | RE12-14 | 5ʹ- TAATGAGAAATGTGCTTTG-3ʹ |
| FHEXA- | 5ʹ- TTCTAGGGTGATGGAGCAAC-3ʹ | ||
| FHEXA- | 5ʹ- TGAGCTGCTCCAAGACTCAA-3ʹ | ||
| RHEXA- | 5ʹ- AAGGTTCCTGAAGAGTCCTTG-3ʹ | ||
Identified mutations in HEXA and HEXB, and the clinical and laboratory findings in this study
| Case-AMA | Homo IVS2+1G>A | Known | NA | Onset: 1 year Death: 3.8 years Psychomotor degeneration, mild vision deficiency, recurrent seizures, paralysis | ||
| Case-MOE | Suspected Homo c.622delG in her both parent | 6 | Novel | NA | Onset: 6 months Death: 4.5 years Seizures (sometimes), mild vision deficiency, psychomotor degeneration, paralysis | |
| Case-DAN | Homo exon 6–10 deletion (new) | Novel | HexA: 0.00 nmol/ml/min (normal: 0.96–1.78) HexAB: 51.66 nmol/ml/min (normal: 18.59–31.33) HexB: 54.51 nmol/ml/min (normal: 5.76–15.77) | Onset: 5 months Death: 2.6 years Psychomotor degeneration, mild vision deficiency, seizures (sometimes), paralysis | ||
| Case-RAM | Homo c.919G>A, p.E307K | Novel | NA | Onset: 8 months Death: 2.1 years Recurrent seizures, vision deficiency, psychomotor degeneration, paralysis | ||
| Case-NEGAH | Homo c.619A>G, p.I207V | VOUS | NA | Onset: 7.5 months Death: 2.5 years Seizures (rarely), vision deficiency, psychomotor degeneration, paralysis | ||
| Case-MOHR | Homo c.1597C>T, p.R533C | Known | HexAB: 0.2 mU/ml (normal: 16.7–40.7) HexA: 0.02 mU/ml (normal: 0.47–2.60) HexB: 0.02 mU/ml (normal: 3.94–14) | Onset: 8 months Death: 2.5 years Psychomotor degeneration, vision deficiency, seizures (sometimes), paralysis | ||
| Case-HANIE | Homo c.1597C>T, p.R533C | Known | HexAB: 0.8 mU/ml (normal: 16.7–40.7) HexA: 0.11 mU/ml (normal: 0.47–2.60) HexB: 0.06 mU/ml (normal: 3.94–14) | Case-YAS Onset: 9 months Death: 2 years Psychomotor degeneration, vision deficiency, recurrent seizures, paralysis | ||
| Case-YAS | Homo c.1597C>T, p.R533C | Known | HexAB: 0.0 mU/ml (normal: 16.7–40.7) HexA: 0.06 mU/ml (normal: 0.47–2.60) HexB: 0.02 mU/ml (normal: 3.94–14) | Onset: 1.6 year Death: 5 years Psychomotor degeneration, vision deficiency, recurrent seizures, hypotonia, paralysis | ||
| Case-TALP | Homo c.1597C>T, p.R533C | Known | NA | Onset: 1.6 year Death: 5 years Psychomotor degeneration, vision deficiency, seizures, paralysis | ||
| Case-SADA | Homo c.1597C>T, p.R533C | Known | NA | Onset: 6 months Death: 4.5 years Psychomotor degeneration, vision deficiency, seizures (at the late stage of disease), hypotonia, poor head control, paralysis |
Abbreviations: HexA: beta-hexosaminidase A, HexB: beta-hexosaminidase B, HexAB: beta-hexosaminidase A and B; Homo, homozygous; NA, not applicable; VOUS, variant of uncertain significance.
Figure 1Different Alu elements across the HEXA gene. The most prevalent Alu element across this gene are the AluS class, mainly AluSx. As seen, the possible mechanism for the deletion of exons 6–10 is recombination between AluSz6 in intron 5 and AluJo in intron 10.
Figure 2The breakpoint of the deletion and deleted region in the HEXA gene. (a) The red arrows show the breakpoint of the deletion (the region between these red arrows was completely deleted), blue arrows show the deleted region in the Sanger sequencing chromatogram and blue letters indicate the deleted nucleotides, including all of exons 6–10. Blue-highlighted nucleotides show the sequence of AluSz6, and yellow-highlighted nucleotides represent AluJo. (b) The homology between AluSz6 and AluJo is indicated as 76%, which is used for recombination between these two Alu elements. (c) Sequencing data confirmed that the breakpoint of the large deletion in HEXA was due to the Alu elements. (d) Normal and mutant HEXA proteins that resulted from the large deletion are compared, indicating the loss of 192 amino acids from the protein. In the normal sequence, the brown underline shows the deleted residues, and in the mutant sequence, the underline shows the breakpoints of the deletion and also the two joined amino acids after this deletion.
Figure 3The similarity between AluSz6 and AluJo and its flanking sequence. There was high homology between these Alu elements, and the microhomology between 18 nucleotides of the AluSz6 and the sequence at the breakpoints helps to determine the occurrence of recombination between these sequences, leading to Alu-mediated deletion. Blue letters show homology between AluSz6 and AluJo. Red letters show microhomology at the breakpoints.
Figure 4PCR products from patients with deletion of exons 6–10 in HEXA. (a) PCR for different exons of HEXA in patients for whom exons 6–10 were deleted as there were no PCR bands for them (here, only we show deletion of exons 6–8 from this deleted block). (b) PCR products using primers upstream of AluJo and AluSx in intron 5 and downstream of AluJo in intron 10. PCR revealed that the proband with the exon 6–10 deletion only had PCR bands produced from primers designed around the Alu elements (1,000 bp for AluSx-AluJo and 1,500 bp for AluJo-AluJo), revealing that the homozygous status due to the amplification of the reduced size of the exon 6–10 block resulted from this deletion. In our patient’s parents, not only were the bands amplified from the primers around the Alu elements detected but all of the exons of HEXA also produced PCR bands (here, only the PCR bands around the Alu elements are given for parents), indicating its heterozygous status. E, exon.
Figure 5(a) Sanger data from the family with a novel c.919G>A (p.E307K) missense mutation. The reference sequence was obtained from the Ensembl database (https://www.ensembl.org/). Reference nucleotide and residues are highlighted in yellow. (b) Comparative alignment of the amino acids of HEXA across different species. The E307 residue is highly conserved during evolution. The conserved glutamic acid residue is shown in the rectangular box. Protein sequences were obtained from National Center for Biotechnology (NCBI). Symbols: (*)—identical amino acids; (:)—only similar amino acids. Pongo abelii: one of two species of orangutans; Macaca fascicularis: one species of macaque; Bos taurus (domestic cow): a species of oxen; Ovis aries: domestic sheep; Felis catus: domestic cat; Sus scrofa: wild boar or Eurasian wild pig; Rattus norvegicus: brown rat, also referred to as common rat, street rat and Norway rat; Mus musculus: house mouse; Gallus gallus (the red junglefowl): a type of domesticated fowl. (c) The Sanger chromatogram revealed a novel heterozygous c.622delG, p.D208Ifsx15 in both parents of the proband. Reference nucleotides are highlighted in yellow.
Bioinformatics analysis of the c.919G>A[p.E307K] in HEAX with their corresponding damage scores
| PolyPhen | 1 | GranthamScore | 56 |
| ScoreCADD | 35 | ChimpAllele | C |
| AsianHapMapFreq | NA | DbSNPValidation | NA |
| SIFT:DAMAGING | 0 | Fathmm | DAMAGING, −4.74 |
| ConsScoreGERP | 5.6 | EuropeanHapMapFreq | NA |
| Mutation Assessor | 4.425 | MutationTaster | Disease-causing |
| ScorePhastCons | 0.99 | AfricanHapMapFreq | NA |
Abbreviation: N/A, not applicable.